Danaher reports first-quarter earnings that beat analysts' estimates though revises forward guidance on costs related to acquisition of GE's biopharma business.
Few parts of the market have more volatility than the small caps in this sector.
Healthcare giant Johnson & Johnson reports first-quarter earnings lower than a year earlier but still above analysts' forecasts.
Drugmaker Catalent reaches an agreement to buy closely held Paragon Bioservices, the latest deal in the burgeoning gene-therapy treatment space.
Here are updates on small biotech/biopharma names I have profiled before.
Gilead Sciences is partnering with Novo Nordisk to help combat liver disease.
Wave Life Sciences now says its Huntington's disease treatment data won't be available until the end of the year.
The battle for subscribers and content among streaming video providers is only going to get more intense in 2019. Here is why Disney is the superior investment over Netflix.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.